Elanco Animal Health (ELAN) Other financing activities (2017 - 2026)

Elanco Animal Health has disclosed Other financing activities across 10 years of filings, most recently posting -$15.0 million for Q1 2026.

• Other financing activities for Q1 2026 came in at -$15.0 million, down 114.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.0 million (changed 0.0% YoY), and the FY2025 annual result was -$2.0 million, up 88.24% from the prior year.
• Other financing activities came in at -$15.0 million for Q1 2026 at Elanco Animal Health, up from -$17.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $35.0 million in Q3 2025 to a low of -$17.0 million in Q4 2025.
• The 5-year median for Other financing activities is -$7.0 million (2023), against an average of -$4.5 million.
• Peak annual rise in Other financing activities reached 537.5% in 2025, while the deepest fall reached 1200.0% in 2025.
• Elanco Animal Health's Other financing activities stood at $1.0 million in 2022, then slumped by 200.0% to -$1.0 million in 2023, then surged by 700.0% to $6.0 million in 2024, then tumbled by 383.33% to -$17.0 million in 2025, then advanced by 11.76% to -$15.0 million in 2026.
• The last three Other financing activities figures came in at -$15.0 million (Q1 2026), -$17.0 million (Q4 2025), and $35.0 million (Q3 2025), per Business Quant data.